Relay Therapeutics (RLAY) Q2 2026 Earnings

May 5Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.49
-0.45
-0.41
-0.36

Details

Expected EPS
-0.363212
Actual EPS
-0.41
Surprise EPS
-0.05
Surprise Percent
-12.88%

Description

⁨Relay Therapeutics⁩ (⁦RLAY⁩) has reported earnings of ⁦-0.41⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts